Launch of Australia’s biggest myeloma awareness campaign – 38mate

Every week, 38 Australians are diagnosed with myeloma, an incurable blood cancer that develops in the bone marrow. Despite this, many people have never heard of myeloma until they, or a loved one, are...

People living with myeloma to benefit from new Government funded medicine

Myeloma Australia welcomes today’s announcement by the Federal Government that the medicine Darzalex® (also known as daratumumab) will be available on the Pharmaceutical Benefits Scheme (PBS) for Aust...

PBS update: Lenalidomide maintenance and changes to bortezomib access due to COVID19

Lenalidomide (Revlimid®) maintenance post autologous stem cell transplant We are delighted to announce that as of 1 April 2020 the pharmaceutical benefits scheme (PBS) have listed lenalidomide (Revlim...

ASH conference 2019

Earlier this month, a team from Myeloma Australia visited Orlando, Florida in the USA for the annual American Society of Hematology (ASH) conference as invited guests of the International Myeloma Foun...

PBAC Meeting Nov: Daratumumab combination and Pomalidomide combination

A couple of weeks ago we sent out a special advocacy edition of the Muster to inform you of the latest submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) for the upcoming November PB...